Keywords
coronavirus infection, cardiovascular diseases, pathogenesis, diagnosis, European Society of Cardiology.
How to Cite
Katerenchuk, I. (2021). Summary of the European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID‑19 pandemic: part 1 — epidemiology, pathophysiology, and diagnosis. The Practitioner, (4), 24-34. Retrieved from https://plr.com.ua/index.php/journal/article/view/666
Abstract
The article provides an overview of the keypoints of the European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic (2021). Issues of epidemiology, pathogenesis and diagnosis of CVD are covered. The importance of innovations for practitioners is analyzed, the main directions of realization of the keypoints in everyday clinical practice by doctors of different specialties are determined.
References
1. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID‑19 pandemic: part 1 — epidemiology,
pathophysiology, and diagnosis. The Task Force for the management of COVID‑19 of the European Society of Cardiology Received 23 April 2021; revised
8 July 2021; editorial decision 10 September 2021; accepted 13 September 2021. Режим доступу: https://academic.oup.com/eurheartj/advance-аrticle/doi/10.1093/eurheartj/ehab696/6429144.
2. Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016;36:78-80.
3. Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID‑19 in Washington State. JAMA. Published online March 19,2020. doi:10.1001/jama.2020.4326.
4. Choi AD, Abbara S, Branch KR, Feuchtner GM, Ghoshhajra B, Nieman K, Pontone G, Villines TC, Williams MC, Blankstein R. Society of Cardiovascular Computed
Tomography Guidance for Use of Cardiac Computed Tomography Amidst the COVID‑19 Pandemic. Journal of Cardiovascular Computed Tomograph. https://doi.org/10.1016/j.jcct.2020.03.002
5. Darlington MR. Hypoprothrombinemia during concomitant therapy with warfarin and saquinavir. Ann Pharmacother. 1997;31:647.
6. Elkind MS, Harrington RA, Benjamin IJ. Role of the American Heart Association in the Global COVID‑19 Pandemic. Originally published 17 Mar 2020. https://doi.org/10.1161/CIRCULATIONAHA.120.046749
7. Gao Y. Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID19. J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25770.
8. Grasselli G. Critical Care Utilization for the COVID‑19 Outbreak in Lombardy, Italy. JAMA 2020. Published Online 13.03.2020, DOI:10.1001/jama.2020.4031.
9. Li, B, Yang, J, Zhao, F. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID‑19 in China. Clin Res Cardiol. 2020. https://doi.org/10.1007/s00392-020-01626-9; https://link.springer.com/article/10.1007%2Fs00392-020-01626-9 34
10. Liu K, Fang YY, Deng Y et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020. Feb 7. doi:
10.1097/CM9.0000000000000744.
11. Liu Y, Yang Y, Zhang C et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020;63:364-374.
12. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID‑19) outbreak in China: summary of a report of
72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. Published online February 24, 2020. doi: 10.1001/jama.2020.2648. https://jamanetwork.com/journals/jama/fullarticle/2762130
13. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‑19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020. Published online 24.02.2020, DOI:10.1001/jama.2020.2648.
pathophysiology, and diagnosis. The Task Force for the management of COVID‑19 of the European Society of Cardiology Received 23 April 2021; revised
8 July 2021; editorial decision 10 September 2021; accepted 13 September 2021. Режим доступу: https://academic.oup.com/eurheartj/advance-аrticle/doi/10.1093/eurheartj/ehab696/6429144.
2. Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016;36:78-80.
3. Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID‑19 in Washington State. JAMA. Published online March 19,2020. doi:10.1001/jama.2020.4326.
4. Choi AD, Abbara S, Branch KR, Feuchtner GM, Ghoshhajra B, Nieman K, Pontone G, Villines TC, Williams MC, Blankstein R. Society of Cardiovascular Computed
Tomography Guidance for Use of Cardiac Computed Tomography Amidst the COVID‑19 Pandemic. Journal of Cardiovascular Computed Tomograph. https://doi.org/10.1016/j.jcct.2020.03.002
5. Darlington MR. Hypoprothrombinemia during concomitant therapy with warfarin and saquinavir. Ann Pharmacother. 1997;31:647.
6. Elkind MS, Harrington RA, Benjamin IJ. Role of the American Heart Association in the Global COVID‑19 Pandemic. Originally published 17 Mar 2020. https://doi.org/10.1161/CIRCULATIONAHA.120.046749
7. Gao Y. Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID19. J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25770.
8. Grasselli G. Critical Care Utilization for the COVID‑19 Outbreak in Lombardy, Italy. JAMA 2020. Published Online 13.03.2020, DOI:10.1001/jama.2020.4031.
9. Li, B, Yang, J, Zhao, F. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID‑19 in China. Clin Res Cardiol. 2020. https://doi.org/10.1007/s00392-020-01626-9; https://link.springer.com/article/10.1007%2Fs00392-020-01626-9 34
10. Liu K, Fang YY, Deng Y et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020. Feb 7. doi:
10.1097/CM9.0000000000000744.
11. Liu Y, Yang Y, Zhang C et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020;63:364-374.
12. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID‑19) outbreak in China: summary of a report of
72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. Published online February 24, 2020. doi: 10.1001/jama.2020.2648. https://jamanetwork.com/journals/jama/fullarticle/2762130
13. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‑19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020. Published online 24.02.2020, DOI:10.1001/jama.2020.2648.
Downloads
Download data is not yet available.